Larry Jasinski
See the following -
ReWalk Featured in VA National Multi-Center Clinical Exoskeleton Trial
ReWalk Robotics Ltd...announced that the Department of Veterans Affairs ("VA") has publicly listed details of a national, multi-center study utilizing the Company's Personal 6.0 Exoskeleton Systems. The VA released full details of the study titled, "Exoskeleton Assisted-Walking in Persons With SCI: Impact on Quality of Life" on the clinical trials section of the National Institutes of Health (NIH) website (www.clinicaltrials.gov Identifier: NCT02658656). Several key components of the study outlined by the VA, include...
- Login to post comments
ReWalk Robotics Exoskeleton Deemed Medically Necessary by Independent Medical Review Organization
ReWalk Robotics Ltd...announced today that a commercial health plan in the Northwest region of the United States has approved coverage and reimbursement for a ReWalk Personal exoskeleton system, following the ruling of an external independent review organization that overturned the health plan's initial denial of coverage. The beneficiary of the ReWalk device is a surgeon who suffered a spinal cord injury and currently uses a manual custom wheelchair 11 hours a day at work. Use of the ReWalk will permit the beneficiary to stand up and ambulate both at work and in the home.
- Login to post comments
VA Purchases an Additional 20 ReWalk Exoskeleton Systems for First Ever Multi-Center Exoskeleton Clinical Trials
ReWalk Robotics Ltd...announced that the U.S. Department of Veterans Affairs ("VA") has purchased an additional 20 ReWalk Personal Systems to support initiation of their national multi-center clinical trial. The VA clinical trial is the first-ever U.S. study to examine the impact of exoskeleton use in the home or daily life setting. The study will include 160 participants across the country, with six VA medical centers participating in the first phase across California, Florida, Massachusetts, Texas and Virginia...
- Login to post comments